Placebo Meeting: Raz LabPlacebo Meeting 2012

Program

Day 0: May 22nd, 2012

International guests arrive in Montreal

5:30 PM Welcome to Montreal - Thomson House (see address below)

Day 1: May 23rd, 2012

Chair: Cory Harris

Opening Morning:
Thomson House, McGill Downtown Campus
Ballroom, 2nd floor
3650 McTavish, Montreal, Quebec, H3A 1Y2
Link to Directions (will open in a new window)

Breakfast 8:00 - 8:30

8:15-8:30 Collect and register your clicker
8:45-9:00 Welcome and introductory remarks (Cory Harris and Veronica de Jong)
9:00-9:30 How to use your clicker, individual introductions, and clicker questions (Amir Raz)
9:30-10:30 White Paper Introduction and Videos (Cory Harris)
10:30-10:45 Coffee Break
10:45-11:30 White Paper Discussion

Relocate to:
Montreal Neurological Institute and Hospital, McGill Downtown Campus
Room: de Grandpré Communications Centre
3801 University Street
Montreal, Quebec, H3A 2B5
Link to Directions (will open in a new window)

Lunch
12:00-1:00
Montreal Neurological Institute, de Grandpré Communications Centre Atrium
Presentation Series 1 - Therapeutic Potentials of Placebos
1:00-1:30 Karin Meissner, Dr. Med., Medical Psychology, Ludwig Maximilians University, Germany
Placebo effects in clinical trials: The influence of expectancy on health outcomes
1:30-1:45 Discussants: Luana Colloca and Mark Sinyor
1:45-1:55 Open Discussion
2:00-2:30 W. Grant Thompson MD, FRCPC, FACG Emeritus Professor of Medicine, University of Ottawa
Therapeutic Power of Placebos – Implications of the Placebo Effect
2:30-2:45 Discussants: Margrit Fassler and Abraham Fuks
2:45-2:55 Open Discussion
2:55-3:15 Coffee Break
3:15-3:45 John Kelley, Ph. D., Psychology, Harvard University, USA
Placebos without Deception: Testing the Efficacy of Open-Label Placebo
3:45-4:00 Discussants: Jean-Luc Mommaerts and Laurence Kirmayer
4:00-4:10 Open Discussion
4:10-4:25 Short presentation: Veronica de Jong
4:25-4:35 Open Discussion
4:35-5:30 Group discussion - Therapeutic potentials of placebos, coordinated by Chair
7:30 Social Dinner (Location TBA)

Day 2: May 24rd, 2012

Chair: Ian Gold

Montreal Neurological Institute and Hospital, McGill Downtown Campus
Room: de Grandpré Communications Centre
3801 University Street
Montreal, Quebec, H3A 2B5
Link to Directions (will open in a new window)


Breakfast 8:00 - 8:30

Presentation Series 2 - Culture, Philosophy, and Education
9:00-9:30 Jean-Luc Mommaerts, MD, MSc, PhD Candidate, Medical Science, University of Brussels
Placebo as Communication to Neur(on)al Networks in Chronic Functional Pain
9:30-9:45 Discussants: Michael Lifshitz and Ian Gold
9:45-9:55 Open Discussion
9:55-10:10 Short Presentation: Natasha Campbell
10:10-10:20 Open Discussion
10:20-10:30 Coffee Break
10:30-11:00 Laurence Kirmayer, Healing Fictions: The Politics and Practice of Placebos
11:00-11:15 Luana Colloca and Peter Krummenacher
11:15-11:25 Open Discussion
Presentation Series 3- Ethical and Logistical Implications of Placebos in the Clinic
11:25-11:55 Peter Krummenacher, PhD, Clinical Psychology and Psychotherapy, University of Basel, Switerland
Neuroscientific Aspects of Modulating Beliefs & Expectations and their Possible Implications for Personalized Medicine
11:55-12:10 Discussants: Elia Abi-Jaoude and Joey Kossowski
12:10-12:20 Open Discussion
Lunch 12:20 - 1:15 Montreal Neurological Institute, de Grandpré Communications Centre Atrium
1:15-1:30 Short Presentation: Erica Abbey
1:30-1:40 Open Discussion
1:40-2:10 Luana Colloca, MD, PhD, Placebo Research, National Institutes of Health
Nocebo mechanisms and their implications for patient-physician communication
2:10-2:25 Discussants: Jonathan Kimmelman and Joel Paris
2:25-2:35 Open Discussion
2:35-2:50 Coffee Break
Presentation Series 4 - Developing Blueprints to Guide Policy Recommendations for the Use of Placebos in Clinical Practice
2:50-3:20 Stewart Justman, PhD, Director, Liberal Studies Program, University of Montana
Placebos, Consent, and the AMA
3:20-3:35 Discussants: George Weisz and John Kelley
3:35-3:45 Open Discussion
3:45-4:15 Margrit Fassler, Dr. Med., Biomedical Ethics, University of Zurich
The ethical pros and cons of clinical use of placebo
4:15-4:30 Discussants: W. Grant Thompson and Stewart Justman
4:30-4:40 Open Discussion
4:40-5:15 Group discussion and White Paper consensus building coordinated by Chair
5:15-5:30 Closing remarks and thanks coordinated and presented by the organizing committee

Complete and submit conference evaluation forms

Updated as of May 11, 2012

We thank the following sponsors for their generous support for this meeting:

CIHR   McGill University   Jewish General Hospital